AG2R LA Mondiale Gestion D Actifs Invests $1.02 Million in Baxter International Inc. $BAX

Key Points

• AG2R LA Mondiale Gestion D Actifs has invested approximately $1.02 million in Baxter International Inc. by acquiring 29,835 shares, reflecting growing interest from large investors in the company.
• Baxter International recently reported an EPS of $0.59, slightly missing analysts' estimates, while projecting a Q3 2025 EPS guidance of 0.580-0.620.
• The company announced a quarterly dividend of $0.17 per share, indicating a 2.8% yield, despite a negative payout ratio of -226.67%.

AG2R LA Mondiale Gestion D Actifs acquired a new position in Baxter International Inc. (NYSE:BAX - Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 29,835 shares of the medical instruments supplier's stock, valued at approximately $1,021,000.

A number of other hedge funds also recently added to or reduced their stakes in the business. Dodge & Cox lifted its stake in Baxter International by 2.1% in the first quarter. Dodge & Cox now owns 51,458,925 shares of the medical instruments supplier's stock worth $1,761,439,000 after acquiring an additional 1,081,631 shares during the period. Ameriprise Financial Inc. lifted its stake in Baxter International by 1.1% in the first quarter. Ameriprise Financial Inc. now owns 7,540,942 shares of the medical instruments supplier's stock worth $258,140,000 after acquiring an additional 83,973 shares during the period. Sound Shore Management Inc. CT lifted its stake in Baxter International by 13.7% in the first quarter. Sound Shore Management Inc. CT now owns 2,825,902 shares of the medical instruments supplier's stock worth $96,731,000 after acquiring an additional 341,321 shares during the period. Amundi lifted its stake in Baxter International by 9.5% in the first quarter. Amundi now owns 1,444,705 shares of the medical instruments supplier's stock worth $45,292,000 after acquiring an additional 125,431 shares during the period. Finally, ARGA Investment Management LP lifted its stake in Baxter International by 52.5% in the first quarter. ARGA Investment Management LP now owns 1,327,946 shares of the medical instruments supplier's stock worth $45,456,000 after acquiring an additional 457,345 shares during the period. 90.19% of the stock is owned by hedge funds and other institutional investors.

Baxter International Stock Performance

Shares of NYSE BAX traded down $0.41 during midday trading on Friday, reaching $23.28. 1,324,023 shares of the stock were exchanged, compared to its average volume of 5,372,588. The company has a quick ratio of 1.49, a current ratio of 2.30 and a debt-to-equity ratio of 1.30. The firm has a market cap of $11.96 billion, a price-to-earnings ratio of -77.46, a PEG ratio of 0.76 and a beta of 0.61. The firm has a 50-day simple moving average of $25.10 and a two-hundred day simple moving average of $29.08. Baxter International Inc. has a twelve month low of $21.33 and a twelve month high of $39.57.

Baxter International (NYSE:BAX - Get Free Report) last posted its earnings results on Thursday, July 31st. The medical instruments supplier reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.60 by ($0.01). The firm had revenue of $2.81 billion for the quarter, compared to analysts' expectations of $2.82 billion. Baxter International had a negative net margin of 1.42% and a positive return on equity of 16.96%. Baxter International's revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period last year, the firm earned $0.68 earnings per share. Baxter International has set its Q3 2025 guidance at 0.580-0.620 EPS. FY 2025 guidance at 2.420-2.520 EPS. As a group, analysts anticipate that Baxter International Inc. will post 2.48 EPS for the current fiscal year.

Baxter International Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 1st. Stockholders of record on Friday, August 29th will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend is Friday, August 29th. Baxter International's dividend payout ratio is presently -226.67%.

Analysts Set New Price Targets

Several research firms have commented on BAX. The Goldman Sachs Group lowered shares of Baxter International from a "buy" rating to a "neutral" rating and set a $25.00 price target for the company. in a research report on Friday, August 1st. Evercore ISI decreased their price target on shares of Baxter International from $44.00 to $42.00 and set an "outperform" rating for the company in a research report on Tuesday, July 8th. UBS Group decreased their price target on shares of Baxter International from $35.00 to $24.00 and set a "neutral" rating for the company in a research report on Monday, August 4th. Wall Street Zen lowered shares of Baxter International from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Finally, Citigroup decreased their price target on shares of Baxter International from $34.00 to $32.00 and set a "neutral" rating for the company in a research report on Wednesday, July 9th. Three research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $30.11.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.